Results 141 to 150 of about 69,057 (285)

The gatekeepers of growth: The neural roles and regulation of growth hormone‐releasing hormone neurons

open access: yesJournal of Neuroendocrinology, EarlyView.
Abstract The neuroendocrine control of growth is mediated by the hypothalamic–pituitary–somatic (HPS) axis. This involves the hypothalamic release of growth hormone‐releasing hormone (GHRH), which stimulates the pituitary secretion of growth hormone (GH).
Bradley B. Jamieson
wiley   +1 more source

Preclinical Study of a Dual-Target Molecular Probe Labeled with 68Ga Targeting SSTR2 and FAP

open access: yesPharmaceuticals
Objective: Currently, 68Ga-labeled somatostatin analogs (SSAs) are the most commonly used imaging agents for patients with neuroendocrine tumors (NETs) in clinical practice, demonstrating good results in tumor diagnosis.
Huanhuan Liu   +9 more
doaj   +1 more source

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. [PDF]

open access: yesCancers (Basel), 2023
Delbart W   +11 more
europepmc   +1 more source

11C‐Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma

open access: yesJournal of Neuroendocrinology, EarlyView.
Abstract Early detection of metastases and timely surgical intervention play a crucial role in the management of neuroendocrine tumors. In large‐sized pheochromocytomas and sympathetic paragangliomas (PPGL), functional imaging with positron emission tomography (PET) is recommended, as it improves the detection of metastases, which may go undetected on ...
Achyut Ram Vyakaranam   +8 more
wiley   +1 more source

Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors. [PDF]

open access: yesCancers (Basel), 2022
Watanabe H   +16 more
europepmc   +1 more source

Figure 3 from Upregulation of Somatostatin Receptor Type 2 Improves <sup>177</sup>Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model

open access: gold, 2023
Rupali Sharma   +6 more
openalex   +1 more source

Lower density of calretinin‐immunopositive neurons in the putamen of subjects with schizophrenia

open access: yesJournal of Anatomy, Volume 246, Issue 4, Page 505-516, April 2025.
Recent neuroimaging and histological studies highlight the striatum as a key area involved in SCH, but the specific impairment of neuronal subtypes in subcortical structures is not fully understood. This study is the first detailed investigation of neuroanatomical changes in the putamen in SCH, specifically examining the density of calretinin ...
Paz Kelmer   +4 more
wiley   +1 more source

Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors. [PDF]

open access: yesFront Oncol, 2023
Bocchini M   +13 more
europepmc   +1 more source

Calcineurin controls the expression of numerous genes in cerebellar granule cells [PDF]

open access: yes, 2003
Ashby, Dominique S   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy